SC 13G Filing

Company

GT Biopharma, Inc.

Filed

January 25, 2005

Accession Number

0001019687-05-000156

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →